About the Company
adc therapeutics is a biotechnology company located in lausanne, vaud, switzerland.
Please visit adctherapeutics.com for more information about the company.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ADCT News
ADC Therapeutics SA (NYSE:ADCT) Q4 2023 Earnings Call Transcript
March 13, 2024 ADC Therapeutics SA misses on earnings expectations. Reported EPS is $-1.03 EPS, expectations were $-0.47.
ADC Therapeutics SA ADCT
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit
LAUSANNE, Switzerland, March 06, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) announced today that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the ...
ADC Therapeutics SA (NYSE:ADCT) Q4 2023 Earnings Call Transcript
ADC Therapeutics SA (NYSE:ADCT) Q4 2023 Earnings Call Transcript March 13, 2024 ADC Therapeutics SA misses on earnings expectations. Reported EPS is $-1.03 EPS, expectations were $-0.47.
ADC Therapeutics SA: ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit
LAUSANNE, Switzerland, March 06, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) announced today that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the ...
ADC Therapeutics SA (ADCT) Q4 2023 Earnings Call Transcript
Welcome to the ADC Therapeutics Fourth Quarter and Full-Year 2023 Financial Results Conference Call. My name is Norma and I will be your operator for today's call. At this time, all participants ...
ADC Therapeutics SA (NYSE:ADCT) Q4 2023 Earnings Call Transcript
Mohamed Zaki: Yeah, thanks all for your attention and interest in ADC Therapeutics. Between now and our next earnings call, we expect to share some important updates on LOTIS-7, on the futility ...
ADC Therapeutics SA (NYSE:ADCT) Q4 2023 Earnings Call Transcript
And one, it’s nice to see a win for an ADC. It reinforces the efficacy of ADCs. But, two, we haven’t seen any data on that trial other than the headline that Pfizer put out in terms of the ...
Q4 2023 ADC Therapeutics SA Earnings Call
Naureen Quibria; Analyst; Capital One Securities, Inc. Brian Cheng; Analyst; JPMorgan Chase & Co. Greg Renza; Analyst; RBC Capital Markets Kelly Shi; Analyst; Jefferies Financial Group Inc Welcome to ...
Loading the latest forecasts...